![Ashish Khanna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashish Khanna
Directeur/Bestuurslid bij
Fountain Therapeutics, Inc.
Profiel
Ashish Khanna was the founder of Vaxcyte, Inc. founded in 2013, where he held the title of Chief Business Officer.
Currently, he is a Director at Fountain Therapeutics, Inc. and a Partner at Pivotal Bioventure Partners Investment Advisor LLC since 2017.
Dr. Khanna's former jobs include being an Independent Director at Bolt Biotherapeutics, Inc. from 2018 to 2021, a Director at Evommune, Inc., a Team Leader at Bristol Myers Squibb Co., a Board Observer at Sutro Biopharma, Inc., a Board Observer at AlloCure, Inc., and the President & Chief Business Officer at Imagen Biotech, Inc. Dr. Khanna's education includes an undergraduate degree from the University of Mumbai in 1997, a doctorate from The State University of New York, and an MBA from The Wharton School of the University of Pennsylvania in 2006.
Actieve functies van Ashish Khanna
| Bedrijven | Functie | Begin |
|---|---|---|
Pivotal Bioventure Partners Investment Advisor LLC
 Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Private Equity Investor | 01-09-2017 |
Fountain Therapeutics, Inc.
 Fountain Therapeutics, Inc. Packaged SoftwareTechnology Services Develops first-in-class therapies for diseases and conditions that are caused by aging | Directeur/Bestuurslid | - |
Eerdere bekende functies van Ashish Khanna
| Bedrijven | Functie | Einde |
|---|---|---|
| BOLT BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 13-12-2021 |
| EVOMMUNE, INC. | Directeur/Bestuurslid | - |
| VAXCYTE, INC. | Oprichter | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | - |
Opleiding van Ashish Khanna
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology Develops cell therapies for the treatment of kidney diseases, organ transplants and multi-organ injuries | Health Technology |
Imagen Biotech, Inc.
 Imagen Biotech, Inc. BiotechnologyHealth Technology Develops therapeutics for blinding diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bolt Biotherapeutics, Inc.
 Bolt Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Pivotal Bioventure Partners Investment Advisor LLC
Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure invests in companies located in the United States and Europe. The firm focuses on biotechnology and innovative therapeutic products. It participates in seed, early and later stage capital transactions. | Finance |
Fountain Therapeutics, Inc.
Fountain Therapeutics, Inc. Packaged SoftwareTechnology Services Develops first-in-class therapies for diseases and conditions that are caused by aging | Technology Services |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
